HK1039795A1 - 能在心臟中組織特異性表達的重組腺病毒 - Google Patents

能在心臟中組織特異性表達的重組腺病毒

Info

Publication number
HK1039795A1
HK1039795A1 HK02101338.7A HK02101338A HK1039795A1 HK 1039795 A1 HK1039795 A1 HK 1039795A1 HK 02101338 A HK02101338 A HK 02101338A HK 1039795 A1 HK1039795 A1 HK 1039795A1
Authority
HK
Hong Kong
Prior art keywords
recombinant adenovirus
heart
specific expression
tissue specific
adenovirus vector
Prior art date
Application number
HK02101338.7A
Other languages
English (en)
Inventor
K‧R‧基耶
王義斌
S‧埃文斯
Original Assignee
加利福尼亞大學董事會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 加利福尼亞大學董事會 filed Critical 加利福尼亞大學董事會
Publication of HK1039795A1 publication Critical patent/HK1039795A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
HK02101338.7A 1998-09-11 2002-02-22 能在心臟中組織特異性表達的重組腺病毒 HK1039795A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9996098P 1998-09-11 1998-09-11
PCT/US1999/020730 WO2000015821A1 (en) 1998-09-11 1999-09-10 Recombinant adenovirus for tissue specific expression in heart

Publications (1)

Publication Number Publication Date
HK1039795A1 true HK1039795A1 (zh) 2002-05-10

Family

ID=22277433

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101338.7A HK1039795A1 (zh) 1998-09-11 2002-02-22 能在心臟中組織特異性表達的重組腺病毒

Country Status (10)

Country Link
US (1) US6451594B1 (zh)
EP (1) EP1109925B1 (zh)
JP (1) JP2002525064A (zh)
CN (1) CN1159445C (zh)
AT (1) ATE294874T1 (zh)
AU (1) AU5819599A (zh)
CA (1) CA2342283C (zh)
DE (1) DE69925134T2 (zh)
HK (1) HK1039795A1 (zh)
WO (1) WO2000015821A1 (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745416B2 (en) * 1995-04-11 2010-06-29 The Regents Of The University Of California Method for in vivo regulation of cardiac muscle contractility
US20090239940A1 (en) * 1997-07-22 2009-09-24 Del Monte Federica Treating heart failure and ventricular arrhythmias
CZ20031569A3 (cs) * 2000-12-07 2003-11-12 Gencell S. A. Polynukleotidy obsahující fragment sekvence v protisměru od genu CARP, vektory a expresní kazety, které je obsahují, a jejich použití
EP1477556A1 (de) * 2003-05-16 2004-11-17 Heart Biosystems GmbH Verfahren zur Selektion von kardiomyogenen Zellen oder Herzmuskelzellen aus gemischten Zellpopulationen
WO2005023292A1 (en) * 2003-09-03 2005-03-17 The General Hospital Corporation Methods of treating restenosis
US8859273B2 (en) * 2003-12-24 2014-10-14 Medtronic, Inc. Methods of using HCN genes to treat cardiac arrhythmias
US20050244377A1 (en) * 2003-12-24 2005-11-03 Daniel Sigg Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel
US7840263B2 (en) 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7828711B2 (en) 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US11512326B2 (en) 2009-05-26 2022-11-29 University Of Florida Research Foundation, Incorporated Small angiotensin peptide expression system in mammalian cells
PL3254703T3 (pl) * 2011-04-22 2020-10-05 The Regents Of The University Of California Wiriony wirusa towarzyszącego adenowirusom z różnymi kapsydami i sposoby ich zastosowania
KR20140035967A (ko) * 2011-05-26 2014-03-24 유니버시티 오브 워싱톤 세포 및 유전자에 기반한 심장 기능을 개선하는 방법
US9066966B2 (en) 2013-02-01 2015-06-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
CA2940513C (en) 2013-03-11 2023-08-15 University Of Florida Research Foundation, Inc. Delivery of card protein as therapy for ocular inflammation
CA2907799A1 (en) 2013-05-31 2014-12-04 The Regents Of The University Of California Adeno-associated virus variants and methods of use thereof
WO2015124546A1 (en) * 2014-02-19 2015-08-27 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii- Cnic Aav vectors for the treatment of ischemic and non-ischemic heart disease
EP3107939B1 (en) 2014-02-19 2020-06-17 University of Florida Research Foundation, Inc. Delivery of nrf2 as therapy for protection against reactive oxygen species
WO2015138628A1 (en) 2014-03-11 2015-09-17 University Of Florida Research Foundation, Inc. Use of aav-expressed m013 protein as an anti-inflammatory therapeutic
CA2942776C (en) 2014-03-17 2023-01-24 Adverum Biotechnologies, Inc. Polyneucleotide cassette and expression vector for expression of a gene in cone cells using truncated m-opsin promoter
JP6577960B2 (ja) * 2014-04-22 2019-09-18 メディツィニッシュ ホホシュール ハノーバー 心肥大の治療および診断のためのｌｎｃＲＮＡ
KR20170137730A (ko) 2015-03-02 2017-12-13 애드베룸 바이오테크놀로지스, 인코포레이티드 망막 추상체에 폴리뉴클레오타이드의 유리체 내 전달을 위한 조성물 및 방법
AU2016235163B2 (en) 2015-03-24 2022-03-24 The Regents Of The University Of California Adeno-associated virus variants and methods of use thereof
CN105754997B (zh) * 2016-03-30 2019-02-26 华中农业大学 狂犬病毒drv-ah08株的先导rna及其在制备预防与治疗狂犬病毒的药品中的应用
MX2019001276A (es) 2016-07-29 2019-06-13 Univ California Viriones de virus adenoasociados con cápside variante y métodos para su uso.
WO2018075798A1 (en) 2016-10-19 2018-04-26 Adverum Biotechnologies, Inc. Modified aav capsids and uses thereof
EP3676373A4 (en) 2017-08-28 2021-06-09 The Regents of The University of California CAPSID VARIANTS OF ADENO-ASSOCIATED VIRUSES AND METHOD OF USING THEREOF
CN110823870A (zh) * 2018-08-10 2020-02-21 武汉大学人民医院（湖北省人民医院） 一种基于上转化发光技术的心脏节律与功能的光控制系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE307212T1 (de) * 1992-11-18 2005-11-15 Arch Dev Corp Adenovirus-gelenkter gen-transfer zum herz-und glatten vaskulären muskel
US5747245A (en) 1994-06-14 1998-05-05 La Jolla Cancer Research Foundation Nucleic acids encoding Fas associated proteins and screening assays using same
US5856152A (en) * 1994-10-28 1999-01-05 The Trustees Of The University Of Pennsylvania Hybrid adenovirus-AAV vector and methods of use therefor
US5834306A (en) * 1994-12-23 1998-11-10 Sri International Tissue specific hypoxia regulated therapeutic constructs
US5652224A (en) 1995-02-24 1997-07-29 The Trustees Of The University Of Pennsylvania Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
US5792453A (en) 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
WO1998010088A1 (en) * 1996-09-06 1998-03-12 Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
US5772993A (en) 1997-01-21 1998-06-30 The University Of Virginia Patent Foundation Osteocalcin promoter-based toxic gene therapy for the treatment of calcified tumors and tissues

Also Published As

Publication number Publication date
DE69925134D1 (de) 2005-06-09
ATE294874T1 (de) 2005-05-15
US6451594B1 (en) 2002-09-17
CN1159445C (zh) 2004-07-28
CA2342283A1 (en) 2000-03-23
WO2000015821A1 (en) 2000-03-23
DE69925134T2 (de) 2006-01-19
EP1109925A1 (en) 2001-06-27
EP1109925B1 (en) 2005-05-04
CN1325451A (zh) 2001-12-05
JP2002525064A (ja) 2002-08-13
AU5819599A (en) 2000-04-03
CA2342283C (en) 2004-05-25

Similar Documents

Publication Publication Date Title
HK1039795A1 (zh) 能在心臟中組織特異性表達的重組腺病毒
Keck et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF
EP1927660A3 (en) Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
EP1315512A4 (en) NOVIRAL AD TARGETING AND MANIPULATION OF IMMUNE SYSTEM RESPONSE USING TARGETING PEPTIDES
HUP0202882A2 (en) Novel b7-4 molecules and uses therefor
ES2156958T3 (es) Virus hibrido adenovirus-aav y metodo de utilizacion del mismo.
AU5464000A (en) Recombinant adenoviral vectors for cell specific infection and genome integration and expressing chimeric fiber proteins
WO2002012523A3 (en) CELL TYPE SPECIFICITY GENE DELIVERY VECTORS FOR PRIMARY HUMAN CHONDROCYTES
ATE488596T1 (de) Adenovirus/alphavirus-hybrid-vektor zur effektiven verabreichung und expression von therapeutischen genen in tumorzellen
ATE465242T1 (de) Exogene angiogene wachstumsfaktoren exprimierende keratinozyten
IT1298487B1 (it) Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
AU8435698A (en) Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
RU2005137697A (ru) Синтетический ген, кодирующий человеческий раково-эмбриональный антиген, и его применение
RU2006105195A (ru) Синтетический ген, кодирующий человеческий антиген эпидермального фактора роста 2/neu, и его применение
Milas et al. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity
CN102154369A (zh) 一种重组慢病毒载体、重组慢病毒及含有该重组慢病毒的干细胞
EP1203819A3 (en) Anti-inflammatory vectors
US20030008824A1 (en) Stimulation of vascularization with VEGF-B
WO2003092598A3 (en) Treatment for pompe disease
WO2002002148A3 (en) Dual recombinant gene therapy compositions and methods of use
CO5420199A1 (es) Vector adenoviral recombinante para el tratamiento de cirrosis hepatica
CN111465697B (zh) 用于预防或治疗心力衰竭的药物组合物
CA2326053A1 (en) Use of scatter factor to enhance angiogenesis
Reed et al. Construction and characterization of a recombinant adenovirus directing expression of the MAGE‐1 tumor‐specific antigen
ATE355385T1 (de) Herstellung von rekombinanten adenoviren und von adenovirus-genbanken